Arcoma AB (STO:ARCOMA)
Sweden · Delayed Price · Currency is SEK 7.32
-0.18 (-2.40%)
Jan 21, 2026, 5:22 PM CET
Arcoma AB Revenue
Arcoma AB had revenue of 29.89M SEK in the quarter ending September 30, 2025, a decrease of -6.27%. This brings the company's revenue in the last twelve months to 132.94M, down -22.41% year-over-year. In the year 2024, Arcoma AB had annual revenue of 156.81M, down -3.81%.
Revenue (ttm)
132.94M
Revenue Growth
-22.41%
P/S Ratio
0.81
Revenue / Employee
4.29M
Employees
31
Market Cap
107.31M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 156.81M | -6.21M | -3.81% |
| Dec 31, 2023 | 163.02M | 37.97M | 30.36% |
| Dec 31, 2022 | 125.05M | 7.92M | 6.76% |
| Dec 31, 2021 | 117.13M | -287.00K | -0.24% |
| Dec 31, 2020 | 117.42M | -16.26M | -12.16% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Getinge AB | 35.85B |
| Swedish Orphan Biovitrum AB | 27.85B |
| Medicover AB | 25.67B |
| Elekta AB | 17.57B |
| Asker Healthcare Group AB | 16.41B |
| AddLife AB | 10.53B |
| Vimian Group AB | 4.65B |
| Vitrolife AB | 3.51B |